Structure-based virtual screening and lead identification of novel protein kinase inhibitors through integrated computational approaches
Results presented show that C48 is an attractive scaffold for the future development of selective BCR-ABL type-II inhibitors targeting the inactive DFG-out conformation, and is confirmed by DFT calculations, indicating suitability for stable intermolecular interactions.